Mometasone Furoate — Class III drug recall D-1173-2022
Terminated recall by Glenmark Pharmaceuticals Inc., USA, reported 2022-07-13, distributed nationwide. Defective Container
| Recall number | D-1173-2022 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States |
| Recall initiated | 2022-06-16 |
| Classified | 2022-07-01 |
| Reported by FDA | 2022-07-13 |
| Terminated | 2026-02-24 |
| Distributed | Nationwide (US) |
| Reason classes | packaging |
| NDC | 68462-0385, 68462-0385-02, 68462-0385-37 |
| Expiration dates | 2022-06, 2023-01, 2023-02, 2023-07, 2023-08, 2023-10 |
Product
Mometasone Furoate, Topical Solution USP, 0.1 % Lotion, a) 30 ml-bottle (NDC 68462-385-37), b) 60 ml-bottle (NDC 68462-385-02), Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Baddi Himachal Pradesh 173205, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah NJ 07430.
Reason for recall
Defective Container
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1173-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.